Gene Therapy Starting Materials Market Size, Share & Trends Report

Gene Therapy Starting Materials Market (2025 - 2030) Size, Share & Trends Analysis Report By Product (Viral Vectors, Plasmid DNA, Cell Lines), By Development Stage, By Application, By End Use, By Region, And Segment Forecasts

Market Segmentation

Gene Therapy Starting Materials Product Outlook (Revenue, USD Billion, 2018 - 2030)
- Viral Vectors
  - Adenovirus
  - Retrovirus
  - Adeno-Associated Virus (AAV)
  - Lentivirus
  - Others
- Plasmid DNA
- Cell Lines
- Others
Gene Therapy Starting Materials Development Stage Outlook (Revenue, USD Billion, 2018 - 2030)
- Pre-clinical Therapeutics
- Clinical Therapeutics
- Marketed Therapeutics
Gene Therapy Starting Materials Application Outlook (Revenue in USD Million, 2018-2030)
- Oncology
- Infectious Disease
- Genetic Disease
- Others
Gene Therapy Starting Materials End Use Outlook (Revenue, USD Billion, 2018 - 2030)
- Biopharmaceutical & Pharmaceutical Companies
- CROs & CMOs
- Others
Gene Therapy Starting Materials Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Gene Therapy Starting Materials Market, By Product
    - Viral Vectors
      - Adenovirus
      - Retrovirus
      - Adeno-Associated Virus (AAV)
      - Lentivirus
      - Others
    - Plasmid DNA
    - Cell Lines
    - Others
  - North America Gene Therapy Starting Materials Market, By Development Stage
    - Pre-clinical Therapeutics
    - Clinical Therapeutics
    - Marketed Therapeutics
  - North America Gene Therapy Starting Materials Market, By Application
    - Oncology
    - Infectious Disease
    - Genetic Disease
    - Others
  - North America Gene Therapy Starting Materials Market, By End Use
    - Biopharmaceutical & Pharmaceutical Companies
    - CROs & CMOs
    - Others
  - U.S.
    - U.S. Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - U.S. Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - U.S. Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - U.S. Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
  - Canada
    - Canada Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - Canada Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - Canada Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - Canada Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
  - Mexico
    - Mexico Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - Mexico Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - Mexico Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - Mexico Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
- Europe
  - Europe Gene Therapy Starting Materials Market, By Product
    - Viral Vectors
      - Adenovirus
      - Retrovirus
      - Adeno-Associated Virus (AAV)
      - Lentivirus
      - Others
    - Plasmid DNA
    - Cell Lines
    - Others
  - Europe Gene Therapy Starting Materials Market, By Development Stage
    - Pre-clinical Therapeutics
    - Clinical Therapeutics
    - Marketed Therapeutics
  - Europe Gene Therapy Starting Materials Market, By Application
    - Oncology
    - Infectious Disease
    - Genetic Disease
    - Others
  - Europe Gene Therapy Starting Materials Market, By End Use
    - Biopharmaceutical & Pharmaceutical Companies
    - CROs & CMOs
    - Others
  - Germany
    - Germany Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - Germany Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - Germany Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - Germany Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
  - UK
    - UK Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - UK Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - UK Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - UK Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
  - France
    - France Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - France Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - France Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - France Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
  - Italy
    - Italy Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - Italy Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - Italy Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - Italy Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
  - Spain
    - Spain Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - Spain Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - Spain Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - Spain Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
  - Sweden
    - Sweden Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - Sweden Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - Sweden Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - Sweden Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
  - Denmark
    - Denmark Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - Denmark Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - Denmark Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - Denmark Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
  - Norway
    - Norway Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - Norway Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - Norway Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - Norway Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
- Asia Pacific
  - Asia Pacific Gene Therapy Starting Materials Market, By Product
    - Viral Vectors
      - Adenovirus
      - Retrovirus
      - Adeno-Associated Virus (AAV)
      - Lentivirus
      - Others
    - Plasmid DNA
    - Cell Lines
    - Others
  - Asia Pacific Gene Therapy Starting Materials Market, By Development Stage
    - Pre-clinical Therapeutics
    - Clinical Therapeutics
    - Marketed Therapeutics
  - Asia Pacific Gene Therapy Starting Materials Market, By Application
    - Oncology
    - Infectious Disease
    - Genetic Disease
    - Others
  - Asia Pacific Gene Therapy Starting Materials Market, By End Use
    - Biopharmaceutical & Pharmaceutical Companies
    - CROs & CMOs
    - Others
  - China
    - China Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - China Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - China Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - China Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
  - Japan
    - Japan Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - Japan Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - Japan Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - Japan Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
  - India
    - India Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - India Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - India Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - India Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
  - South Korea
    - South Korea Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - South Korea Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - South Korea Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - South Korea Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
  - Australia
    - Australia Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - Australia Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - Australia Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - Australia Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
  - Thailand
    - Thailand Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - Thailand Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - Thailand Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - Thailand Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
- Latin America
  - Latin America Gene Therapy Starting Materials Market, By Product
    - Viral Vectors
      - Adenovirus
      - Retrovirus
      - Adeno-Associated Virus (AAV)
      - Lentivirus
      - Others
    - Plasmid DNA
    - Cell Lines
    - Others
  - Latin America Gene Therapy Starting Materials Market, By Development Stage
    - Pre-clinical Therapeutics
    - Clinical Therapeutics
    - Marketed Therapeutics
  - Latin America Gene Therapy Starting Materials Market, By Application
    - Oncology
    - Infectious Disease
    - Genetic Disease
    - Others
  - Latin America Gene Therapy Starting Materials Market, By End Use
    - Biopharmaceutical & Pharmaceutical Companies
    - CROs & CMOs
    - Others
  - Brazil
    - Brazil Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - Brazil Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - Brazil Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - Brazil Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
  - Argentina
    - Argentina Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - Argentina Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - Argentina Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - Argentina Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
- Middle East and Africa (MEA)
  - MEA Gene Therapy Starting Materials Market, By Product
    - Viral Vectors
      - Adenovirus
      - Retrovirus
      - Adeno-Associated Virus (AAV)
      - Lentivirus
      - Others
    - Plasmid DNA
    - Cell Lines
    - Others
  - MEA Gene Therapy Starting Materials Market, By Development Stage
    - Pre-clinical Therapeutics
    - Clinical Therapeutics
    - Marketed Therapeutics
  - MEA Gene Therapy Starting Materials Market, By Application
    - Oncology
    - Infectious Disease
    - Genetic Disease
    - Others
  - MEA Gene Therapy Starting Materials Market, By End Use
    - Biopharmaceutical & Pharmaceutical Companies
    - CROs & CMOs
    - Others
  - South Africa
    - South Africa Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - South Africa Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - South Africa Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - South Africa Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
  - UAE
    - UAE Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - UAE Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - UAE Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - UAE Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
  - Saudi Arabia
    - Saudi Arabia Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - Saudi Arabia Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - Saudi Arabia Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - Saudi Arabia Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others
  - Kuwait
    - Kuwait Gene Therapy Starting Materials Market, By Product
      - Viral Vectors
        
        Adenovirus
        
        Retrovirus
        
        Adeno-Associated Virus (AAV)
        
        Lentivirus
        
        Others
      - Plasmid DNA
      - Cell Lines
      - Others
    - Kuwait Gene Therapy Starting Materials Market, By Development Stage
      - Pre-clinical Therapeutics
      - Clinical Therapeutics
      - Marketed Therapeutics
    - Kuwait Gene Therapy Starting Materials Market, By Application
      - Oncology
      - Infectious Disease
      - Genetic Disease
      - Others
    - Kuwait Gene Therapy Starting Materials Market, By End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - CROs & CMOs
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments